Probiotic treatment during neonatal age provides optimal protection against experimental asthma through the modulation of microbiota and T cells

International Immunology

Volumn 30, Issue 4, 2018, Pages 155-169

  Nunes, Caroline Fraga ^a,b   Nogueira, Jeane S ^a,b   Vianna, Pedro Henrique Oliveira ^a   Ciambarella, Bianca Torres ^c   Rodrigues, Patrícia Machado ^c   Miranda, Karla Rodrigues ^a   Lobo, Leandro Araújo ^a   Domingues, Regina Maria Cavalcanti Pillotto ^a   Busch, Mileane ^a,d   Atella, Georgia Correa ^a,d   Vale, André Macedo ^a   Bellio, Maria ^a   Nóbrega, Alberto ^a   Canto, Fábio B ^a,b   Fucs, Rita ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Institute of Molecular Entomology   (Brazil)

Author keywords

Allergy; Commensal microbiota; Immunoregulation; Tolerance; Treg

Indexed keywords

BUTYRIC ACID; CD4 ANTIGEN; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1; PROBIOTIC AGENT; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; ALLERGEN; ANTIGEN; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIFIDOBACTERIUM; BRONCHOALVEOLAR LAVAGE FLUID; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CECUM; CONTROLLED STUDY; EXPERIMENTAL ASTHMA; INTESTINE FLORA; LACTOBACILLUS; MICROFLORA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; SYMPTOM; T LYMPHOCYTE; ANIMAL; ASTHMA; BLOOD; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PREGNANCY; T LYMPHOCYTE SUBPOPULATION;

ADULT; ALLERGENS; ANIMALS; ANTIGENS; ASTHMA; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOMODULATION; INFANT, NEWBORN; MICE; MICROBIOTA; PREGNANCY; PROBIOTICS; T-LYMPHOCYTE SUBSETS;

EID: 85045468866     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxy011     Document Type: Article

References (81)

1. Eder, W., Ege, M. J. and von Mutius, E. 2006. The asthma epidemic. N. Engl. J. Med. 355:2226.
2. Lambrecht, B. N. and Hammad, H. 2015. The immunology of asthma. Nat. Immunol. 16:45.
3. Lambrecht, B. N. and Hammad, H. 2012. The airway epithelium in asthma. Nat. Med. 18:684.
4. Schaub, B., Lauener, R. and von Mutius, E. 2006. The many faces of the hygiene hypothesis. J. Allergy Clin. Immunol. 117:969.
5. Kozyrskyj, A. L., Ernst, P. and Becker, A. B. 2007. Increased risk of childhood asthma from antibiotic use in early life. Chest 131:1753.
6. Tanaka, S., Kobayashi, T., Songjinda, P., et al. 2009. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 56:80.
7. Abrahamsson, T. R., Jakobsson, H. E., Andersson, A. F., Björkstén, B., Engstrand, L. and Jenmalm, M. C. 2014. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44:842.
8. Bisgaard, H., Li, N., Bonnelykke, K., et al. 2011. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 128:646.
9. Penders, J., Stobberingh, E. E., van den Brandt, P. A. and Thijs, C. 2007. The role of the intestinal microbiota in the development of atopic disorders. Allergy 62:1223.
10. Wang, M., Karlsson, C., Olsson, C., et al. 2008. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J. Allergy Clin. Immunol. 121:129.
11. Gore, C., Munro, K., Lay, C., et al. 2008. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested casecontrol study investigating the fecal microbiota of infants. J. Allergy Clin. Immunol. 121:135.
12. Cahenzli, J., Köller, Y., Wyss, M., Geuking, M. B. and McCoy, K. D. 2013. Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe 14:559.
13. Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. and Brown, P. O. 2007. Development of the human infant intestinal microbiota. PLoS Biol. 5:e177.
14. Yatsunenko, T., Rey, F. E., Manary, M. J., et al. 2012. Human gut microbiome viewed across age and geography. Nature 486:222.
15. Tamburini, S., Shen, N., Wu, H. C. and Clemente, J. C. 2016. The microbiome in early life: implications for health outcomes. Nat. Med. 22:713.
16. Adkins, B. 2000. Development of neonatal Th1/Th2 function. Int. Rev. Immunol. 19:157.
17. Adkins, B. and Du, R. Q. 1998. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J. Immunol. 160:4217.
18. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911.
19. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W. and Boirivant, M. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-betabearing regulatory cells. J. Immunol. 174:3237.
20. Karimi, K., Inman, M. D., Bienenstock, J. and Forsythe, P. 2009. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 179:186.
21. Robinson, D. S. 2009. Regulatory T cells and asthma. Clin. Exp. Allergy 39:1314.
22. Sakaguchi, S. 2011. Regulatory T cells: history and perspective. Methods Mol. Biol. 707:3.
23. Atarashi, K., Tanoue, T., Shima, T., et al. 2011. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337.
24. Ivanov, I. I., Atarashi, K., Manel, N., et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485.
25. Tan, T. G., Sefik, E., Geva-Zatorsky, N., et al. 2016. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl Acad. Sci. USA 113:E8141.
26. Billingham, R. E., Brent, L. and Medawar, P. B. 1953. Actively acquired tolerance of foreign cells. Nature 172:603.
27. Guerau-de-Arellano, M., Martinic, M., Benoist, C. and Mathis, D. Neonatal tolerance revisited: a perinatal window for AIRE control of autoimmunity. J. Exp. Med. 206:1245.
28. Verhasselt, V. 2010. Neonatal tolerance under breastfeeding influence. Curr. Opin. Immunol. 22:623.
29. Feleszko, W., Jaworska, J., Rha, R. D., et al. 2007. Probioticinduced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin. Exp. Allergy 37:498.
30. Harb, H., van Tol, E. A., Heine, H., et al. 2013. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin. Exp. Allergy 43:353.
31. Arrieta, M. C., Stiemsma, L. T., Amenyogbe, N., Brown, E. M. and Finlay, B. 2014. The intestinal microbiome in early life: health and disease. Front. Immunol. 5:427.
32. Wang, G., Miyahara, Y., Guo, Z., Khattar, M., Stepkowski, S. M. and Chen, W. 2010. "Default" generation of neonatal regulatory T cells. J. Immunol. 185:71.
33. Dowling, D. J. and Levy, O. 2014. Ontogeny of early life immunity. Trends Immunol. 35:299.
34. Bettelli, E., Carrier, Y., Gao, W., et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
35. Silva, P. M., Alves, A. C., Serra, M. F., et al. 2001. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme. Br. J. Pharmacol. 134:283.
36. Bacchetti de Gregoris, T., Aldred, N., Clare, A. S. and Burgess, J. G. 2011. Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J. Microbiol. Methods 86:351.
37. Fireman, P. 2003. Understanding asthma pathophysiology. Allergy Asthma Proc. 24:79.
38. Dominguez-Bello, M. G., Costello, E. K., Contreras, M., et al. 2010. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107:11971.
39. Bäckhed, F., Roswall, J., Peng, Y., et al. 2015. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17:690.
40. Donskey, C. J., Hujer, A. M., Das, S. M., Pultz, N. J., Bonomo, R. A. and Rice, L. B. 2003. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods 54:249.
41. Zoetendal, E. G., Akkermans, A. D. and De Vos, W. M. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64:3854.
42. Kim, H. J., Kim, Y. J., Lee, S. H., Yu, J., Jeong, S. K. and Hong, S. J. 2014. Effects of Lactobacillus rhamnosus on allergic march model by suppressing Th2, Th17, and TSLP responses via CD4+CD25+Foxp3+ Tregs. Clin. Immunol. 153:178.
43. Jang, S., Kim, H., Kim, Y., et al. 2012. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4+CD25+Foxp3+ T cells. Asthma Immunol. Res. 4:150.
44. Ren, J. J., Yu, Z., Yang, F. L., et al. 2015. Effects of Bifidobacterium breve feeding strategy and delivery modes on experimental allergic rhinitis mice. PLoS One 10:e0140018.
45. Morrison, D. J. and Preston, T. 2016. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189.
46. Furusawa, Y., Obata, Y., Fukuda, S., et al. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446.
47. Arpaia, N., Campbell, C., Fan, X., et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451.
48. Kanda, T., Nishida, A., Ohno, M., et al. 2016. Enterococcus durans TN-3 induces regulatory T cells and suppresses the development of dextran sulfate sodium (DSS)-induced experimental colitis. PLoS One 11:e0159705.
49. Azad, M. B. and Kozyrskyj, A. L. 2012. Perinatal programming of asthma: the role of gut microbiota. Clin. Dev. Immunol. 2012:932072.
50. Renz, H., Brandtzaeg, P. and Hornef, M. 2011. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat. Rev. Immunol. 12:9.
51. Arboleya, S., Sánchez, B., Milani, C., et al. 2015. Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J. Pediatr. 166:538.
52. Isolauri, E., Salminen, S. and Ouwehand, A. C. 2004. Microbialgut interactions in health and disease. Probiotics. Best Pract. Res. Clin. Gastroenterol. 18:299.
53. Vaarala, O. 2003. Immunological effects of probiotics with special reference to lactobacilli. Clin. Exp. Allergy 33:1634.
54. Boyle, R. J. and Tang, M. L. 2006. The role of probiotics in the management of allergic disease. Clin. Exp. Allergy 36:568
55. Martinez, F. D. 2014. The human microbiome. Early life determinant of health outcomes. Ann. Am. Thorac. Soc. 11(Suppl. 1):S7.
56. Sudo, N., Sawamura, S., Tanaka, K., Aiba, Y., Kubo, C. and Koga, Y. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739.
57. Wu, C. T., Chen, P. J., Lee, Y. T., Ko, J. L. and Lue, K. H. 2016. Effects of immunomodulatory supplementation with Lactobacillus rhamnosus on airway inflammation in a mouse asthma model. J. Microbiol. Immunol. Infect. 49:625.
58. Stiemsma, L. T. and Turvey, S. E. 2017. Asthma and the microbiome: defining the critical window in early life. Allergy Asthma Clin. Immunol. 13:3.
59. Olszak, T., An, D., Zeissig, S., et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489.
60. Grönlund, M. M., Lehtonen, O. P., Eerola, E. and Kero, P. 1999. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J. Pediatr. Gastroenterol. Nutr. 28:19.
61. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357:1076.
62. Penders, J., Thijs, C., van den Brandt, P. A., et al. 2007. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56:661.
63. Björkstén, B., Naaber, P., Sepp, E. and Mikelsaar, M. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin. Exp. Allergy 29:342.
64. Böttcher, M. F., Nordin, E. K., Sandin, A., Midtvedt, T. and Björkstén, B. 2000. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin. Exp. Allergy 30:1590.
65. Garn, H., Neves, J. F., Blumberg, R. S. and Renz, H. 2013. Effect of barrier microbes on organ-based inflammation. J. Allergy Clin. Immunol. 131:1465
66. Martínez, J. L. 2017. Effect of antibiotics on bacterial populations: a multi-hierarchical selection process. F1000Res 6:51.
67. Schwab, E. M., Wilkes, J., Korgenski, K., Hersh, A. L., Pavia, A. T. and Stevens, V. W. 2016. Risk factors for recurrent Clostridium difficile infection in pediatric inpatients. Hosp. Pediatr. 6:339.
68. Hill, D. A., Hoffmann, C., Abt, M. C., et al. 2010. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 3:148.
69. De La Cochetière, M. F., Durand, T., Lalande, V., Petit, J. C., Potel, G. and Beaugerie, L. 2008. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb. Ecol. 56:395.
70. Solomon, K. 2013. The host immune response to Clostridium difficile infection. Ther. Adv. Infect. Dis. 1:19.
71. Sun, M., Wu, W., Liu, Z. and Cong, Y. 2017. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J. Gastroenterol. 52:1.
72. McIntyre, A., Gibson, P. R. and Young, G. P. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 34:386.
73. Medina, V., Afonso, J. J., Alvarez-Arguelles, H., Hernández, C. and González, F. 1998. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer. JPEN J. Parenter. Enteral Nutr. 22:14.
74. Canto, F. B., Junior, C. L., Teixeira, I. A., Bellio, M., Nóbrega, A. and Fucs, R. 2008. Susceptibility of neonatal T cells and adult thymocytes to peripheral tolerance to allogeneic stimuli. Immunology 125:387.
75. Adkins, B., Leclerc, C. and Marshall-Clarke, S. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553.
76. Gao, Q., Rouse, T. M., Kazmerzak, K. and Field, E. H. 1999. CD4+CD25+ cells regulate CD8 cell anergy in neonatal tolerant mice. Transplantation 68:1891.
77. Yang, S., Fujikado, N., Kolodin, D., Benoist, C. and Mathis, D. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 348:589.
78. Weiss, J. M., Bilate, A. M., Gobert, M., et al. 2012. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ Treg cells. J. Exp. Med. 209:1723.
79. Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. and Macfarlane, G. T. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221.
80. Vinolo, M. A., Rodrigues, H. G., Nachbar, R. T. and Curi, R. 2011. Regulation of inflammation by short chain fatty acids. Nutrients 3:858.
81. Trompette, A., Gollwitzer, E. S., Yadava, K., et al. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:159.